High frequencies of de novo CNVs in bipolar disorder and schizophrenia.
- Authors
- Malhotra, Dheeraj; McCarthy, Shane; Michaelson, Jacob J; Vacic, Vladimir; Burdick, Katherine E; Yoon, Seungtai; Cichon, Sven; Corvin, Aiden; Gary, Sydney; Gershon, Elliot S; Gill, Michael; Karayiorgou, Maria; Kelsoe, John R; Krastoshevsky, Olga; Krause, Verena; Leibenluft, Ellen; Levy, Deborah L; Makarov, Vladimir; Bhandari, Abhishek; Malhotra, Anil K; McMahon, Francis J; NΓΆthen, Markus M; Potash, James B; Rietschel, Marcella; Schulze, Thomas G; Sebat, Jonathan
- Year
- 2011
- Journal
- Neuron
- PMID
- 22196331
- DOI
- 10.1016/j.neuron.2011.11.007
- PMCID
- PMC3921625
While it is known that rare copy-number variants (CNVs) contribute to risk for some neuropsychiatric disorders, the role of CNVs in bipolar disorder is unclear. Here, we reasoned that a contribution of CNVs to mood disorders might be most evident for de novo mutations. We performed a genome-wide analysis of de novo CNVs in a cohort of 788 trios. Diagnoses of offspring included bipolar disorder (nΒ = 185), schizophrenia (nΒ = 177), and healthy controls (nΒ = 426). Frequencies of de novo CNVs were significantly higher in bipolar disorder as compared with controls (ORΒ = 4.8 [1.4,16.0], pΒ = 0.009). De novo CNVs were particularly enriched among cases with an age at onset younger than 18 (ORΒ = 6.3 [1.7,22.6], pΒ = 0.006). We also confirmed a significant enrichment of de novo CNVs in schizophrenia (ORΒ = 5.0 [1.5,16.8], pΒ = 0.007). Our results suggest that rare spontaneous mutations are an important contributor to risk for bipolar disorder and other major neuropsychiatric diseases.
Detection, Validation, and Breakpoint Sequencing of De Novo CNVs in BDRepresentative examples of microarray data and sequencing results are provided for deletions detected in two subjects with diagnoses of BD, 410-10142 (panel I) and 410-10127 (panel II).(A) De novo CNVs were identified from whole-genome scans of the child, mother, and father, using the NimbleGen HD2 platform.(B) CNV validation and breakpoint refinement was performed by analysis of the trio using a custom Agilent microarray with dense probe coverage of the target region (~200 bp spacing).(C) Deletion breakpoints were determined by PCR and Sanger sequencing.(D) UCSC genome browser tracks of known genes are shown to scale with a track for de novo deletions displayed in red.
LLM interpretation
This figure presents the detection and validation of de novo copy number variants (CNVs) in two subjects (410-10142 and 410-10127) across four panels. Panels A and B show microarray Log2Ratio plots for the child, mother, and father, where the child exhibits a distinct dip in signal indicating a deletion not present in the parents. Panel C displays Sanger sequencing chromatograms identifying the specific deletion breakpoints, and Panel D uses UCSC genome browser tracks to map these red-highlighted de novo deletions relative to known genes and genomic coordinates.
Detection, Validation, and Breakpoint Sequencing of De Novo CNVs in SCZRepresentative examples of microarray data and sequencing results are provided for deletions detected in two subjects with diagnoses of SCZ, 02-0104 (panel I) and 02-0047 (panel II).(A) De novo CNVs were identified from whole-genome scans of the child, mother, and father, using the NimbleGen HD2 platform.(B) CNV validation and breakpoint refinement was performed by analysis of the trio using a custom Agilent microarray with dense probe coverage of the target region (~200 bp spacing).(C) Deletion breakpoints were determined by PCR and Sanger sequencing.(D) UCSC genome browser tracks of known genes are shown to scale with a track for de novo deletions displayed in red.
LLM interpretation
This figure presents the detection and validation of de novo copy number variants (CNVs) in two subjects with schizophrenia (02-0104 and 02-0047). Panels A and B show microarray Log2Ratio plots across genome order for the child, mother, and father, where a dip in the child's signal indicates a deletion absent in the parents. Panel C displays Sanger sequencing chromatograms identifying specific deletion breakpoints, and Panel D uses UCSC genome browser tracks to map these red-highlighted de novo deletions relative to known genes (e.g., *CSMD3* and *UGT8*).
Survival Analysis of De Novo CNVs and Age at Onset in BD and SCZWe performed a survival analysis/Kaplan-Meier test to analyze the effect of de novo mutations on age at onset in BD(n = 185, panel A) and SCZ (n = 177, panel B). This test determines whether βtime to diagnosisβ differs systematically between patients who have de novo mutations and those who do not. The test is formalized by performing the Mantel-Haenszel test on the survival curves and reporting the resulting p value.
LLM interpretation
This figure consists of two Kaplan-Meier survival plots (A and B) showing the percentage of subjects not yet diagnosed relative to age at onset for bipolar disorder (BD) and schizophrenia (SCZ). In panel A (BD), subjects with *de novo* mutations (orange line) show an earlier age at onset compared to those without (blue line), with a statistically significant p-value of 0.0368. In panel B (SCZ), the curves for subjects with and without *de novo* mutations overlap significantly, with a non-significant p-value of 0.743.
| Name | Type |
|---|---|
| 15q13.3 deletion | variant |
| 15q13.3 duplication | variant |
| 16p11.2 CNV | variant |
| 1q21.1 duplication | variant |
| 3q29 local | variant |
| 3q29 CNV local | variant |
| 426 control trios local | cohort |
| 45 ASD trios local | cohort |
| 788 trios local | cohort |
| 7q36.3 local | variant |
| age at onset | phenotype |
| arrays local | drug |
| ASD | phenotype |
| ASD cohort local | cohort |
| ASD Subjects local | cohort |
| autism | phenotype |
| autism spectrum disorder | phenotype |
| BBID local | drug |
| BD | phenotype |
| BD cohort local | cohort |
| BiGS study local | cohort |
| BioCarta local | drug |
| bipolar disorder | phenotype |
| Bipolar Genome Study local | cohort |
| bipolar I disorder | phenotype |
| bipolar II disorder | phenotype |
| CACNA1C | gene |
| cases | cohort |
| children | cohort |
| CMIP local | gene |
| CNP | variant |
| CNV | variant |
| CNVs | variant |
| CNVs > 10 kb local | variant |
| control | cohort |
| control population | cohort |
| controls | cohort |
| copy-number polymorphisms local | variant |
| copy-number variants | variant |
| CSMD3 | gene |
| DAVID Bioinformatics Resources 6.7 local | drug |
| deletion | variant |
| deletion adjacent to UGT8 local | variant |
| deletion involving CMIP and PLCG2 local | variant |
| de_novo_CNVs local | variant |
| de novo variant | variant |
| depression | phenotype |
| duplication | variant |
| early age at onset | phenotype |
| early-onset bipolar disorder | phenotype |
| early onset mania local | phenotype |
| exonic deletion of LINGO2 local | variant |
| Familial bipolar disorder local | cohort |
| families | cohort |
| first-degree relatives | cohort |
| full sample | cohort |
| general population | cohort |
| genomic DNA | drug |
| GO_BP local | drug |
| GO_CC local | drug |
| GO_MF local | drug |
| Grigoroiu-Serbanescu et al., 2001 local | cohort |
| Grozeva et al., 2010 local | cohort |
| healthy controls | cohort |
| Hindbrain development local | phenotype |
| inherited CNV local | variant |
| inherited CNVs | variant |
| inherited variants local | variant |
| insertion | variant |
| intellectual disability | phenotype |
| Intermediate-size CNVs local | variant |
| International schizophrenia Consortium | cohort |
| intronic deletion of CSMD3 local | variant |
| KEGG | drug |
| Kelch-type beta propeller local | phenotype |
| Kirov et al., 2011 local | cohort |
| Large inherited duplications (β₯500 kb) local | variant |
| late-onset bipolar disorder local | phenotype |
| Levy2011Controls local | cohort |
| Levy et al., 2011 local | cohort |
| LINGO2 local | gene |
| major depressive disorder | phenotype |
| mania | phenotype |
| Marshall et al., 2008 local | cohort |
| McQuillin et al., 2011 local | cohort |
| MeZOD local | drug |
| MGS | anatomy |
| Molecular Genetics of Schizophrenia local | cohort |
| mood disorders | phenotype |
| Mood Disorder Subjects local | cohort |
| Neural tube development | phenotype |
| Neurodevelopmental local | phenotype |
| neuropsychiatric disorders | phenotype |
| nonallelic homologous recombination local | drug |
| ODZ4 | gene |
| Our Study Sample local | cohort |
| Panther pathway database local | drug |
| parents | cohort |
| patients with bipolar disorder | phenotype |
| PCR primers | drug |
| Pinto et al., 2010 local | cohort |
| PLCG2 local | gene |
| Plink | drug |
| Positive family history of mental illness local | phenotype |
| present family-based study local | cohort |
| previous case-control studies local | cohort |
| Priebe et al., 2011 local | cohort |
| probe ratio data local | drug |
| QC filters local | drug |
| rare alleles of large effect | variant |
| rare CNV | variant |
| rare CNVs | variant |
| Rare CNVs (>100 kb) local | variant |
| rare copy number variants | variant |
| reference population | cohort |
| Response to ethanol local | phenotype |
| Sanders et al., 2011 local | cohort |
| schizoaffective disorder | phenotype |
| schizophrenia | phenotype |
| Schizophrenia Subjects local | cohort |
| SCZ | phenotype |
| SCZ cohort local | cohort |
| Sebat et al., 2007 local | cohort |
| segmental duplication local | drug |
| short interspersed nuclear element local | drug |
| Sporadic bipolar disorder local | cohort |
| Sporadic case local | phenotype |
| sporadic cases | cohort |
| subjects | cohort |
| suicide | phenotype |
| synapse | anatomy |
| Synaptic local | phenotype |
| trios | cohort |
| Twin cohort | cohort |
| UGT8 local | gene |
| Vacic et al. 2011 study local | cohort |
| Xu et al., 2008 local | cohort |
| Xu et al., 2009 local | cohort |
| Zhang et al., 2009 local | cohort |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alternatively spliced mini-exon B in PTPΞ΄ regulates excitatory synapses through cell-type-specific trans-synaptic PTPΞ΄-IL1RAP interaction. | Kim S et al. | β | 2025 | β |
| An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function. | Kambali M et al. | β | 2025 | β |
| Characterizing Rare DNA Copy-Number Variants in Pediatric Obsessive-Compulsive Disorder. | Abdallah SB et al. | β | 2025 | β |
| Copy number variations in RNF216 and postsynaptic membrane-associated genes are associated with bipolar disorder: a case-control study in the Japanese population. | Nakatochi M et al. | β | 2025 | β |
| Functional Neurogenomics to Dissect Disease Mechanisms Across Models. | Zheng X et al. | β | 2025 | β |
| Synaptic and Non-Synaptic Functions of PTPRD: A Receptor Tyrosine Phosphatase at the Crossroads of Neural Circuitry and Metabolism. | Kim S et al. | β | 2025 | β |
| A comprehensive update on genetic inheritance, epigenetic factors, associated pathology, and recent therapeutic intervention by gene therapy in schizophrenia. | R R et al. | β | 2024 | β |
| Pleiotropic functions of TAO kinases and their dysregulation in neurological disorders. | Byeon S et al. | β | 2024 | β |
| Progress and Implications from Genetic Studies of Bipolar Disorder. | Kong L et al. | β | 2024 | β |
| A genome-wide association study identified new variants associated with mathematical abilities in Chinese children. | Zhang L et al. | β | 2023 | β |
| A marker chromosome in psychosis identifies glycine decarboxylase (GLDC) as a novel regulator of neuronal and synaptic function in the hippocampus | Kambali M et al. | β | 2023 | β |
| Copy Number Variations in Neuropsychiatric Disorders. | BΓΌki G et al. | β | 2023 | β |
| Genetics of bipolar disorder: insights into its complex architecture and biology from common and rare variants. | Hara T et al. | β | 2023 | β |
| <i>CSMD3</i> Deficiency Leads to Motor Impairments and Autism-Like Behaviors via Dysfunction of Cerebellar Purkinje Cells in Mice. | Xi K et al. | β | 2023 | β |
| Snapshots from within the cell: Novel trafficking and non trafficking functions of Snap29 during tissue morphogenesis. | Smeele PH et al. | β | 2023 | β |
| Structure, function, and pathology of Neurexin-3. | Zhang R et al. | β | 2023 | β |
| Transposon insertion profiling by sequencing (TIPseq) identifies novel LINE-1 insertions in human sperm. | Berteli TS et al. | β | 2023 | β |
| Attenuated transcriptional response to pro-inflammatory cytokines in schizophrenia hiPSC-derived neural progenitor cells. | Bhat A et al. | β | 2022 | β |
| Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. | Kushima I et al. | β | 2022 | β |
| dbBIP: a comprehensive bipolar disorder database for genetic research. | Li X et al. | β | 2022 | β |
| Distinct but overlapping roles of LRRTM1 and LRRTM2 in developing and mature hippocampal circuits. | Dhume SH et al. | β | 2022 | β |
| Neuroimaging Findings in Neurodevelopmental Copy Number Variants: Identifying Molecular Pathways to Convergent Phenotypes. | Silva AI et al. | β | 2022 | β |
| Pangenome-based genome inference allows efficient and accurate genotyping across a wide spectrum of variant classes. | Ebler J et al. | β | 2022 | β |
| Parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis. | Polga N et al. | β | 2022 | β |
| Putative complement control protein CSMD3 dysfunction impairs synaptogenesis and induces neurodevelopmental disorders. | Song W et al. | β | 2022 | β |
| Putting Genetics to Work in the Psychiatric Clinic. | McMahon FJ | β | 2022 | β |
| Targeting NMDA receptors in neuropsychiatric disorders by drug screening on human neurons derived from pluripotent stem cells. | Zhang W et al. | β | 2022 | β |
| The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases. | Ermis Akyuz E et al. | β | 2022 | β |
| Brain-derived neurotrophic factor in bipolar disorder: Associations with age at onset and illness duration. | Baykara B et al. | β | 2021 | β |
| Clinical and Neurobiological Aspects of TAO Kinase Family in Neurodevelopmental Disorders. | Hu C et al. | β | 2021 | β |
| Common variants of the autism-associated CNTNAP2 gene contribute to the modulatory effect of social function mediated by temporal cortex. | Li D et al. | β | 2021 | β |
| CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients. | Lu N et al. | β | 2021 | β |
| Dysregulation of post-transcriptional modification by copy number variable microRNAs in schizophrenia with enhanced glycation stress. | Yoshikawa A et al. | β | 2021 | β |
| Genetic contributions to bipolar disorder: current status and future directions. | O'Connell KS et al. | β | 2021 | β |
| LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain. | Cornejo F et al. | β | 2021 | β |
| SERINC2 increases the risk of bipolar disorder in the Chinese population. | Yang D et al. | β | 2021 | β |
| Translational genomics and beyond in bipolar disorder. | Zhang C et al. | β | 2021 | β |
| 16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development. | Roth JG et al. | β | 2020 | β |
| A <i>Caenorhabditis elegans</i> Model for Integrating the Functions of Neuropsychiatric Risk Genes Identifies Components Required for Normal Dendritic Morphology. | Aguirre-Chen C et al. | β | 2020 | β |
| Contribution of de novo and inherited rare CNVs to very preterm birth. | Wong HS et al. | β | 2020 | β |
| Copy Number Variations and Expression Levels of Guanylate-Binding Protein 6 Gene Associated with Growth Traits of Chinese Cattle. | Hao D et al. | β | 2020 | β |
| CRISPR-based functional evaluation of schizophrenia risk variants. | Rajarajan P et al. | β | 2020 | β |
| Critical evaluation of copy number variant calling methods using DNA methylation. | Kilaru V et al. | β | 2020 | β |
| Discovery and quality analysis of a comprehensive set of structural variants and short tandem repeats. | Jakubosky D et al. | β | 2020 | β |
| Functional genomics links genetic origins to pathophysiology in neurodegenerative and neuropsychiatric disease. | Wamsley B et al. | β | 2020 | β |
| Genome-wide copy number variation-, validation- and screening study implicates a new copy number polymorphism associated with suicide attempts in major depressive disorder. | Rao S et al. | β | 2020 | β |
| Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population. | Martin CL et al. | β | 2020 | β |
| Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness. | Ching CRK et al. | β | 2020 | β |
| Splice-dependent trans-synaptic PTPΞ΄-IL1RAPL1 interaction regulates synapse formation and non-REM sleep. | Park H et al. | β | 2020 | β |
| Structural basis of liprin-Ξ±-promoted LAR-RPTP clustering for modulation of phosphatase activity. | Xie X et al. | β | 2020 | β |
| Targeted sequencing of the LRRTM gene family in suicide attempters with bipolar disorder. | Reichman RD et al. | β | 2020 | β |
| The genetics of bipolar disorder. | Gordovez FJA et al. | β | 2020 | β |
| Benefits and limitations of genome-wide association studies. | Tam V et al. | β | 2019 | β |
| [Breakthrough in understanding the molecular causes of psychiatric disorders]. | NΓΆthen MM et al. | β | 2019 | β |
| Contribution of Rare Copy Number Variants toΒ Bipolar Disorder Risk Is Limited to Schizoaffective Cases. | Charney AW et al. | β | 2019 | β |
| Essential genetic findings in neurodevelopmental disorders. | Cardoso AR et al. | β | 2019 | β |
| FunVar: A systematic pipeline to unravel the convergence patterns of genetic variants in ASD, a paradigmatic complex disease. | Asif M et al. | β | 2019 | β |
| Gene expression imputation across multiple brain regions provides insights into schizophrenia risk. | Huckins LM et al. | β | 2019 | β |
| Genomic Triplication of the Glycine Decarboxylase Gene and N-Methyl-D-Aspartate Receptor Hypofunction: Improvement by Glycine and D-Cycloserine. | Hashimoto K | β | 2019 | β |
| NGL-3 in the regulation of brain development, Akt/GSK3b signaling, long-term depression, and locomotive and cognitive behaviors. | Lee H et al. | β | 2019 | β |
| Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder. | Lanz TA et al. | β | 2019 | β |
| PsyMuKB: An Integrative De Novo Variant Knowledge Base for Developmental Disorders. | Lin GN et al. | β | 2019 | β |
| Rediscovering the value of families for psychiatric genetics research. | Glahn DC et al. | β | 2019 | β |
| Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene. | Bodkin JA et al. | β | 2019 | β |
| Thalamic connectivity measured with fMRI is associated with a polygenic index predicting thalamo-prefrontal gene co-expression. | Antonucci LA et al. | β | 2019 | β |
| Whole-exome sequencing identifies variants associated with structural MRI markers in patients with bipolar disorders. | Han MR et al. | β | 2019 | β |
| An examination of multiple classes of rare variants in extended families with bipolar disorder. | Toma C et al. | β | 2018 | β |
| Bipolar disorders. | Vieta E et al. | β | 2018 | β |
| Brain Organoids: Expanding Our Understanding of Human Development and Disease. | Chuye LB et al. | β | 2018 | β |
| Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders. | Toma C et al. | β | 2018 | β |
| De Novo Sequence and Copy Number Variants Are Strongly Associated with Tourette Disorder and Implicate Cell Polarity in Pathogenesis. | Wang S et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia. | Narla ST et al. | β | 2018 | β |
| Marker chromosome genomic structure and temporal origin implicate a chromoanasynthesis event in a family with pleiotropic psychiatric phenotypes. | Grochowski CM et al. | β | 2018 | β |
| Structural basis of SALM5-induced PTPΞ΄ dimerization for synaptic differentiation. | Lin Z et al. | β | 2018 | β |
| The role of genetics and genomics in clinical psychiatry. | Hoehe MR et al. | β | 2018 | β |
| The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders. | Amorim IS et al. | β | 2018 | β |
| When genotype is not predictive of phenotype: implications for genetic counseling based on 21,594 chromosomal microarray analysis examinations. | Maya I et al. | β | 2018 | β |
| Whole genome sequencing of 91 multiplex schizophrenia families reveals increased burden of rare, exonic copy number variation in schizophrenia probands and genetic heterogeneity. | Khan FF et al. | β | 2018 | β |
| A hierarchical causal taxonomy of psychopathology across the life span. | Lahey BB et al. | β | 2017 | β |
| A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen. | Chen X et al. | β | 2017 | β |
| Challenges and opportunities for the development of new antipsychotic drugs. | Forray C et al. | β | 2017 | β |
| Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS). | Narla ST et al. | β | 2017 | β |
| Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. | Marshall CR et al. | β | 2017 | β |
| Divergent Levels of Marker Chromosomes in an hiPSC-Based Model ofΒ Psychosis. | Tcw J et al. | β | 2017 | β |
| [Genetics of bipolar disorder]. | Budde M et al. | β | 2017 | β |
| Genetics of Schizophrenia: Overview of Methods, Findings and Limitations. | Henriksen MG et al. | β | 2017 | β |
| Genomic Disorders in Psychiatry-What Does the Clinician Need to Know? | Lowther C et al. | β | 2017 | β |
| High-resolution copy number variation analysis of schizophrenia in Japan. | Kushima I et al. | β | 2017 | β |
| Prenatal genetic counselling for psychiatric disorders. | Inglis A et al. | β | 2017 | β |
| Rare damaging variants in DNA repair and cell cycle pathways are associated with hippocampal and cognitive dysfunction: a combined genetic imaging study in first-episode treatment-naive patients with schizophrenia. | Yang Z et al. | β | 2017 | β |
| Role of LRRTMs in synapse development and plasticity. | Roppongi RT et al. | β | 2017 | β |
| Schizophrenia and the neurodevelopmental continuum:evidence from genomics. | Owen MJ et al. | β | 2017 | β |
| Synaptic activity: An emerging player in schizophrenia. | Sarkar A et al. | β | 2017 | β |
| Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach. | Fernandez BA et al. | β | 2017 | β |
| SZDB: A Database for Schizophrenia Genetic Research. | Wu Y et al. | β | 2017 | β |
| A Case for Returning to Multiplex Families for Further Understanding the Heritability of Schizophrenia: A Psychiatrist's Perspective. | DeLisi LE | β | 2016 | β |
| A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity. | Biamino E et al. | β | 2016 | β |
| Array-based molecular karyotyping in fetuses with isolated brain malformations identifies disease-causing CNVs. | Schumann M et al. | β | 2016 | β |
| Copy number variation in bipolar disorder. | Green EK et al. | β | 2016 | β |
| CUB and Sushi multiple domains 3 regulates dendrite development. | Mizukami T et al. | β | 2016 | β |
| Differential sensory fMRI signatures in autism and schizophrenia: Analysis of amplitude and trial-to-trial variability. | Haigh SM et al. | β | 2016 | β |
| Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations. | Kataoka M et al. | β | 2016 | β |
| [Genomic instability in the brain: chromosomal mosaicism in schizophrenia]. | Yurov YB et al. | β | 2016 | β |
| Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. | Genovese G et al. | β | 2016 | β |
| Joint detection of copy number variations in parent-offspring trios. | Liu Y et al. | β | 2016 | β |
| SALM5 trans-synaptically interacts with LAR-RPTPs in a splicing-dependent manner to regulate synapse development. | Choi Y et al. | β | 2016 | β |
| Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation. | Gazzellone MJ et al. | β | 2016 | β |
| A genome-wide copy number variant study of suicidal behavior. | Gross JA et al. | β | 2015 | β |
| Age-related sperm DNA methylation changes are transmitted to offspring and associated with abnormal behavior and dysregulated gene expression. | Milekic MH et al. | β | 2015 | β |
| Assessing the Power of Exome Chips. | Page CM et al. | β | 2015 | β |
| Assessment of copy number variations in the brain genome of schizophrenia patients. | Sakai M et al. | β | 2015 | β |
| Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities. | Madison JM et al. | β | 2015 | β |
| Childhood-onset schizophrenia case with 2.2Β Mb deletion at chromosome 3p12.2-p12.1 and two large chromosomal abnormalities at 16q22.3-q24.3 and Xq23-q28. | Rudd D et al. | β | 2015 | β |
| Clinically relevant copy number variations detected in cerebral palsy. | Oskoui M et al. | β | 2015 | β |
| CNVs in neuropsychiatric disorders. | Kirov G | β | 2015 | β |
| Connecting Anxiety and Genomic Copy Number Variation: A Genome-Wide Analysis in CD-1 Mice. | BrenndΓΆrfer J et al. | β | 2015 | β |
| Copy number variants encompassing Mendelian disease genes in a large multigenerational family segregating bipolar disorder. | Kember RL et al. | β | 2015 | β |
| Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior. | Genestine M et al. | β | 2015 | β |
| Factors Influencing Short-term Synaptic Plasticity in the Avian Cochlear Nucleus Magnocellularis. | Sanchez JT et al. | β | 2015 | β |
| Genetic and genomic analyses as a basis for new diagnostic nosologies. | Gershon ES et al. | β | 2015 | β |
| Genetic determinants of depression: recent findings and future directions. | Dunn EC et al. | β | 2015 | β |
| Genetics and genomics of psychiatric disease. | Geschwind DH et al. | β | 2015 | β |
| Genetics of complex traits in psychiatry. | Gelernter J | β | 2015 | β |
| Genetic studies of schizophrenia: an update. | Chen J et al. | β | 2015 | β |
| Genomic structural variation in affective, anxiety, and stress-related disorders. | Ono S et al. | β | 2015 | β |
| Imaging Brain Development: Benefiting from Individual Variability. | Sharda M et al. | β | 2015 | β |
| Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia. | Pocklington AJ et al. | β | 2015 | β |
| Recent genetic findings in schizophrenia and their therapeutic relevance. | Harrison PJ | β | 2015 | β |
| Regulation of recombination and genomic maintenance. | Heyer WD | β | 2015 | β |
| Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases. | Lin GN et al. | β | 2015 | β |
| Splicing-Dependent Trans-synaptic SALM3-LAR-RPTP Interactions Regulate Excitatory Synapse Development and Locomotion. | Li Y et al. | β | 2015 | β |
| S-SCAM, a rare copy number variation gene, induces schizophrenia-related endophenotypes in transgenic mouse model. | Zhang N et al. | β | 2015 | β |
| The balancing act of GABAergic synapse organizers. | Ko J et al. | β | 2015 | β |
| The genetics of early-onset bipolar disorder: A systematic review. | Kennedy KP et al. | β | 2015 | β |
| The variation game: Cracking complex genetic disorders with NGS and omics data. | Cui H et al. | β | 2015 | β |
| Abnormal dosage of ultraconserved elements is highly disfavored in healthy cells but not cancer cells. | McCole RB et al. | β | 2014 | β |
| A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. | Psychosis Endophenotypes International Consortium et al. | β | 2014 | β |
| An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis. | Morris DW et al. | β | 2014 | β |
| An inherited small microdeletion at 15q13.3 in a patient with early-onset obsessive-compulsive disorder. | Cappi C et al. | β | 2014 | β |
| Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease. | Flint J et al. | β | 2014 | β |
| Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. | Brielmaier J et al. | β | 2014 | β |
| Control of neural circuit formation by leucine-rich repeat proteins. | de Wit J et al. | β | 2014 | β |
| Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. | Pinto D et al. | β | 2014 | β |
| Copy number variants and therapeutic response to antidepressant medication in major depressive disorder. | Tansey KE et al. | β | 2014 | β |
| Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. | Noor A et al. | β | 2014 | β |
| Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. | McGrath LM et al. | β | 2014 | β |
| Copy number variation in schizophrenia in Sweden. | Szatkiewicz JP et al. | β | 2014 | β |
| Cryptic and complex chromosomal aberrations in early-onset neuropsychiatric disorders. | Brand H et al. | β | 2014 | β |
| De novo CNVs in bipolar affective disorder and schizophrenia. | Georgieva L et al. | β | 2014 | β |
| De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. | McCarthy SE et al. | β | 2014 | β |
| De novo mutations in schizophrenia implicate synaptic networks. | Fromer M et al. | β | 2014 | β |
| Ethical and public policy challenges for pharmacogenomics. | Gershon ES et al. | β | 2014 | β |
| Evolutionary conservation in genes underlying human psychiatric disorders. | Ogawa LM et al. | β | 2014 | β |
| Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. | Kenny EM et al. | β | 2014 | β |
| Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes. | Guipponi M et al. | β | 2014 | β |
| Explaining additional genetic variation in complex traits. | Robinson MR et al. | β | 2014 | β |
| Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. | Cardno AG et al. | β | 2014 | β |
| Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. | Ramos-Quiroga JA et al. | β | 2014 | β |
| Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. | Doherty JL et al. | β | 2014 | β |
| Identification of pathways for bipolar disorder: a meta-analysis. | Nurnberger JI et al. | β | 2014 | β |
| Identification of structural variation in mouse genomes. | Keane TM et al. | β | 2014 | β |
| Identifying Potential Regions of Copy Number Variation for Bipolar Disorder. | Chen YH et al. | β | 2014 | β |
| Large-scale genomics unveils the genetic architecture of psychiatric disorders. | Gratten J et al. | β | 2014 | β |
| Long-term depression-inducing stimuli promote cleavage of the synaptic adhesion molecule NGL-3 through NMDA receptors, matrix metalloproteinases and presenilin/Ξ³-secretase. | Lee H et al. | β | 2014 | β |
| Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene. | Takata A et al. | β | 2014 | β |
| Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. | Ellegood J et al. | β | 2014 | β |
| New developments in the genetics of bipolar disorder. | Shinozaki G et al. | β | 2014 | β |
| Parental age and the risk of bipolar disorders. | Chudal R et al. | β | 2014 | β |
| Proteomic analysis of rat prefrontal cortex after chronic valproate treatment. | Thangavel M et al. | β | 2014 | β |
| Reaching a CNV milestone. | Beaudet AL | β | 2014 | β |
| Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism. | Ionita-Laza I et al. | β | 2014 | β |
| Synaptic dysregulation in a human iPS cell model of mental disorders. | Wen Z et al. | β | 2014 | β |
| The phenotypic manifestations of rare CNVs in schizophrenia. | Merikangas AK et al. | β | 2014 | β |
| The role of F-actin in modulating Clathrin-mediated endocytosis: Lessons from neurons in health and neuropsychiatric disorder. | Loebrich S | β | 2014 | β |
| 1q21.1 Microduplication expression in adults. | Dolcetti A et al. | β | 2013 | β |
| A common 56-kilobase deletion in a primate-specific segmental duplication creates a novel butyrophilin-like protein. | Aigner J et al. | β | 2013 | β |
| A high-resolution enhancer atlas of the developing telencephalon. | Visel A et al. | β | 2013 | β |
| Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. | Gu F et al. | β | 2013 | β |
| An emerging role for Wnt and GSK3 signaling pathways in schizophrenia. | Singh KK | β | 2013 | β |
| A proposal for reframing schizophrenia research. | Molina V et al. | β | 2013 | β |
| Behavior genetics: past, present, future. | Jaffee SR et al. | β | 2013 | β |
| Consideration of plausible genetic architectures for schizophrenia and implications for analytic approaches in the era of next generation sequencing. | Curtis D | β | 2013 | β |
| Distribution of disease-associated copy number variants across distinct disorders of cognitive development. | Pescosolido MF et al. | β | 2013 | β |
| Genetic basis of intellectual disability. | Ellison JW et al. | β | 2013 | β |
| Genetics of bipolar disorder. | Craddock N et al. | β | 2013 | β |
| Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia. | Schwab SG et al. | β | 2013 | β |
| Human spermatogenic failure purges deleterious mutation load from the autosomes and both sex chromosomes, including the gene DMRT1. | Lopes AM et al. | β | 2013 | β |
| Identification of rare copy number variants in high burden schizophrenia families. | Van Den Bossche MJ et al. | β | 2013 | β |
| Impacts of variation in the human genome on gene regulation. | Haraksingh RR et al. | β | 2013 | β |
| LAR-RPTPs: synaptic adhesion molecules that shape synapse development. | Um JW et al. | β | 2013 | β |
| Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients. | Hatzimanolis A et al. | β | 2013 | β |
| Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes. | Mullin AP et al. | β | 2013 | β |
| Phenotypic impact of genomic structural variation: insights from and for human disease. | Weischenfeldt J et al. | β | 2013 | β |
| Protein tyrosine phosphatases PTPΞ΄, PTPΟ, and LAR: presynaptic hubs for synapse organization. | Takahashi H et al. | β | 2013 | β |
| Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. | Lionel AC et al. | β | 2013 | β |
| Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset. | Geoffroy PA et al. | β | 2013 | β |
| Reduced burden of very large and rare CNVs in bipolar affective disorder. | Grozeva D et al. | β | 2013 | β |
| Risk counselling for family members in bipolar disorder and schizophrenia. | Gershon ES | β | 2013 | β |
| The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. | Grayson DR et al. | β | 2013 | β |
| The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants. | Mowry BJ et al. | β | 2013 | β |
| The genomics of schizophrenia: update and implications. | Giusti-RodrΓguez P et al. | β | 2013 | β |
| A genetic model for neurodevelopmental disease. | Coe BP et al. | β | 2012 | β |
| Assessment between Dopamine Receptor D2 (DRD2) Polymorphisms and Schizophrenia in Korean Population. | Cho AR et al. | β | 2012 | β |
| CNVs: harbingers of a rare variant revolution in psychiatric genetics. | Malhotra D et al. | β | 2012 | β |
| De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. | Xu B et al. | β | 2012 | β |
| De novo mutation in schizophrenia. | Rees E et al. | β | 2012 | β |
| De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention. | Gauthier J et al. | β | 2012 | β |
| Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. | Gilman SR et al. | β | 2012 | β |
| Genetic architectures of psychiatric disorders: the emerging picture and its implications. | Sullivan PF et al. | β | 2012 | β |
| Genetics of bipolar disorder: where we are and where we are going. | Nurnberger JI | β | 2012 | β |
| Genomic structural variation in psychiatric disorders. | Rucker JJ et al. | β | 2012 | β |
| Hybridization and amplification rate correction for affymetrix SNP arrays. | Wang Q et al. | β | 2012 | β |
| Identification of a CACNA2D4 deletion in late onset bipolar disorder patients and implications for the involvement of voltage-dependent calcium channels in psychiatric disorders. | Van Den Bossche MJ et al. | β | 2012 | β |
| Implications of genetic findings for understanding schizophrenia. | Owen MJ | β | 2012 | β |
| Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders. | Kalkman HO | β | 2012 | β |
| Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1. | Gokhale A et al. | β | 2012 | β |
| Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not? | Van Den Bossche MJ et al. | β | 2012 | β |
| Schizophrenia genetics: putting all the pieces together. | Girard SL et al. | β | 2012 | β |
| The genetic variability and commonality of neurodevelopmental disease. | Coe BP et al. | β | 2012 | β |
| The hunt for gene effects pertinent to behavioral traits and psychiatric disorders: from mouse to human. | Wahlsten D | β | 2012 | β |
| Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. | Michaelson JJ et al. | β | 2012 | β |
| De novo CNVs in bipolar disorder: recurrent themes or new directions? | Girirajan S et al. | β | 2011 | β |